Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 27, 2025 09:00 ET | Source: SNS Insider pvt ltd

Sickle Cell Disease Treatment Market Size to Reach USD 12.05 Billion by 2032 | CAGR 17.93% – SNS Insider

Austin, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sickle Cell Disease Treatment Market Size & Growth Analysis According to SNS Insider, the global Sickle Cell Disease Treatment Market was valued at USD...
August 14, 2025 13:30 ET | Source: Spherix Global Insights

Which Gene Therapy Technology Wins? New Data from Spherix Global Insights Reveals Emerging Hematologist Preferences in Beta Thalassemia Care

EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- As the first wave of gene therapies for transfusion-dependent β-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging...
June 04, 2025 12:50 ET | Source: Spherix Global Insights

As Interest Grows for New Agents to Treat Thalassemia, Hematologists Begin Early Identification of Ideal Patients for Gene Therapies Vs. New Therapeutic Options

EXTON, PA, June 04, 2025 (GLOBE NEWSWIRE) -- Despite the promise of new curative strategies for beta thalassemia, such as Casgevy (Vertex) and Zynteglo (bluebird bio), most transfusion-dependent...
May 22, 2024 15:18 ET | Source: National Health Regulatory Authority

Bahrain Oncology Centre Amongst the First in the World to Offer Ground-breaking Sickle Cell and Transfusion Dependent Thalassemia Gene Therapy

MUHARRAQ, Bahrain, May 22, 2024 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has achieved a significant milestone, becoming amongst the first centres in the World to offer the...
December 02, 2023 12:59 ET | Source: National Health Regulatory Authority

CASGEVY Gets Bahrain approval for treatment, marking it second country in the world

CASGEVY Gets Bahrain approval for treatment, marking it second country in the world